Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2023 Results: May 11, 2023

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) has announced the schedule for its fourth quarter and fiscal year 2023 financial results. The results will be published on May 11, 2023, at 6:00 am ET, followed by a conference call with investors and analysts at 8:00 am ET the same day. Investors can access the call via a teleconference link provided in the announcement. Additionally, a live webcast will be available on the Haemonetics investor relations website. A replay of the call will be accessible for one year after the event. Haemonetics focuses on innovative medical products aimed at improving patient care and reducing healthcare costs, particularly in blood and plasma component collection and transfusion services.

Positive

• Scheduled publication of Q4 and fiscal year 2023 financial results on May 11, 2023.
• Investor conference call to discuss results demonstrates commitment to transparency.

Negative

• None.

BOSTON, April 25, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2023 financial results at 6:00 am ET on Thursday, May 11, 2023. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on May 11, 2023.

The call can be accessed via teleconference at: Q4 2023 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/wm7hxoqy 

A replay of the conference call and webcast will be available for one year beginning on May 11, 2023 at 11:00 am ET using the conference call webcast link provided in this press release.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:                                                     
Olga Guyette, Sr. Director-Investor Relations & Treasury          
(781) 356-9763                                                                          
olga.guyette@haemonetics.com                                                                                                          

David Trenk, Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com      

Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-fourth-quarter-and-fiscal-year-2023-results-may-11-2023-301807437.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics publish its fourth quarter and fiscal year 2023 financial results?

Haemonetics will publish its financial results on May 11, 2023, at 6:00 am ET.

What time is the Haemonetics conference call for Q4 2023 financial results?

The conference call is scheduled for May 11, 2023, at 8:00 am ET.

How can I access the Haemonetics earnings conference call?

You can access the call via the teleconference link provided in the press release or through the Haemonetics investor relations website.

Will there be a replay of the Haemonetics conference call?

Yes, a replay of the conference call will be available for one year starting from May 11, 2023, at 11:00 am ET.